JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.
WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment managers on Form 13F filed with the Securities and Exchange Commission (SEC).
SAN FRANCISCO, Aug 8, 2025 /PRNewswire/ -- According to a new market research report titled "Transparent Ceramics Market Forecast to 2031 – Global and Regional...
SAN FRANCISCO, Aug 8, 2025 /PRNewswire/ -- According to a new market research report titled "Transparent Ceramics Market Forecast to 2031 – Global and Regional...
Dr. Wenham is Principal investigator on Anixa's CAR-T therapy for Ovarian Cancer
SAN JOSE, Calif., Aug. 8, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or...
BANGALORE, India, Aug. 7, 2025 /PRNewswire/ --
What is the Market Size of Chain Transfer Agents Market?
The global market for Chain Transfer Agents was valued...
TAIPEI, Aug. 7, 2025 /PRNewswire/ -- MiTAC Computing Technology Corporation, a leading server platform designer, manufacturer, and a subsidiary of MiTAC Holdings Corporation (TSE:3706),...
TAIPEI, Aug. 7, 2025 /PRNewswire/ -- MiTAC Computing Technology Corporation, a leading server platform designer, manufacturer, and a subsidiary of MiTAC Holdings Corporation (TSE:3706),...